Invention Grant
- Patent Title: Anti-MSR1 antibodies and methods of use thereof
-
Application No.: US16407099Application Date: 2019-05-08
-
Publication No.: US11377502B2Publication Date: 2022-07-05
- Inventor: Jesper Gromada , Viktoria Gusarova , Amy Han , Sokol Haxhinasto , Christos Kyratsous , Andrew J. Murphy , Thomas Nittoli , William Olson , Matthew Sleeman , Anna Zumsteg
- Applicant: REGENERON PHARMACEUTICALS, INC.
- Applicant Address: US NY Tarrytown
- Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee Address: US NY Tarrytown
- Agency: Squire Patton Boggs (US) LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K47/68 ; A61P31/04 ; A61K39/395 ; A61K39/00 ; A61K47/61 ; A61K47/60 ; A61P9/10 ; A61P37/06 ; A61P3/06 ; A61P19/02 ; A61K31/165 ; A61K31/167 ; A61K31/417 ; A61K31/4985 ; A61K31/5383 ; A61K31/58 ; A61K38/14

Abstract:
Provided herein are antibodies and antigen-binding fragments that bind MSR1 and methods of use thereof. According to certain embodiments, the antibodies bind human MSR1 with high affinity. In certain embodiments, the antibodies bind MSR1 without blocking, or blocking less than 90%, of modified LDL binding to MSR1. In some embodiments, the antibodies bind cell surface expressed-MSR1 and are internalized. The antibodies of the invention may be fully human antibodies. The invention includes anti-MSR1 antibodies, or antigen-binding fragments thereof, conjugated to drugs or therapeutic compounds.
Information query